Amphion Innovations (AMP)

 

AMP Share PerformanceMore

52 week high4.7000 21/04/17
52 week low1.2500 02/08/17
52 week change -1.7500 (-51.85%)
4 week volume5,074,059 25/07/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

AGM Statement

RNS Number: 8103M Amphion Innovations PLC 01 August 2017 Amphion Innovations plc ("Amphion" or "the Company") 1 August 2017 Results of AGM London and New York, 1 August 2017 - Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, today announces that all resolutions were passed at the Annual Gene...

FTSE falls on mixed bag led by utilities, oil majors

London shares opened firmly lower on Wednesday with blue chips retreating on weakness in a palette of sectors, with utili...

Final Results

RNS Number: 3529J Amphion Innovations PLC 28 June 2017 Amphion Innovations plc ("Amphion" or the "Company") Final results London and New York, 28 June 2017 - Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, announces its audited results for the year ended 31 December 2016. Financial Results: Net A...

Amphion partner company agrees merger

Amphion Innovations partner company, m2m Acquisition Inc and North Carolina-based Polarean Inc have signed a defin...

Partner Company m2m Imaging merger update

RNS Number: 6262G Amphion Innovations PLC 31 May 2017 Amphion Innovations plc ("Amphion" or the "Company") 31 May 2017 Partner Company m2m Imaging merger update Amphion Partner Company, m2m Acquisition Inc, and Polarean Inc. to create Polarean Imaging Limited in a cash and share merger Polarean Imaging Limited announces the closing o...

Amphion draws down additional $1.5m

Amphion Innovations has agreed terms for the draw-down of an additional $1,500,000 under the loan facility announced o...

Additional Draw Down on Loan Facility

RNS Number: 8824F Amphion Innovations PLC 22 May 2017 AMPHION INNOVATIONS PLC ("Amphion" or "the Company") Additional Draw Down on Loan Facility London and New York, 22 May 2017 - Amphion Innovations plc (AIM: AMP), the developer of medical, life science, and technology businesses, today announces that the Company has agreed terms...

Amphion draws down additional $500,000

Amphion Innovations has agreed terms for the draw-down of an additional tranche of $500,000 under the loan facility an...

Equity Research (AMP)

Amphion Innovations Plc
26/01/2017
Accessing Fast Growing Early Stage Tech Stocks Not everyone is able to access fast growing technology stocks directly. This could be because of; suitability issues; or lack of portfolio scale to...

Latest discussion posts More

  • Re: Expensive drawdown facility

    What to do? Sell or avoid? Have been watching this, but any upside to Motif will simply mean AMP selling stake to pay the debt/bills? Will any Motif windfall be squandered? ...
    15-Jul-2016
    bobsson
  • Re: Expensive drawdown facility

    Agree wholeheartedly! Conflicted company officers are electing, against their fiduciary duty, to unecessarily bleed our company dry when cheaper funding could clearly be ...
    13-Jul-2016
    nodebt
  • Expensive drawdown facility

    This facility seems very expensive $750,000 borrowed today and $881,000 having to be repaid in less than 4 months time and some of it being used to pay back a previous ...
    13-Jul-2016
    northumbrian-piper

Users' HoldingsMore

Users who hold Amphion Innovations also hold..
MOTIF BIO24%
ASHLEY HOUSE20%
UK OIL & GAS20%
LLOYDS GRP.20%
BP16%

Codes & Symbols

ISINGB00B0DJNP99
SymbolsAMP, LSE:AMP, AMP.L, AMP:LN, LON:AMP, XLON:AMP